- Patients greater than or equal to 18 years old with pathologically confirmed adult T- cell leukemia: smoldering or chronic adult T- cell leukemia as defined by Shimoyama. Patients with previously treated lymphomatous or acute subtypes with clinically indolent behavior indicated by lack of significant symptoms and treatment free interval of greater than 6 months may also be considered eligible.